11 Aug 2022 | 8:27 PM
Research Report
Daily

Equity Research Report: Religare Morning Digest

We reiterate our cautious view and suggest continuing with hedged positions. Also, maintain stock specific trading approach.
12 Dec 2018 | 07:00 AM

  • Aurobindo Pharma’s wholly-owned subsidiary Helix Healthcare BV, Netherlands, has inked an agreement with China-based Shandong Luoxin Pharmaceutical (Luoxin) to establish a JV company in China As per the agreement, Helix will invest UDD 15mn and Luoxin will invest USD 35mn in the proposed JV in the form of equity in a phased manner.
  • Strides Pharma Science announced that its joint venture firm has received approval from US health regulator for Albendazole tablets, used in treatment of certain infections caused by tapeworm.
  • Mindtree.org, the social inclusion platform of Mindtree, announced the successful implementation of its five digital platforms designed to build inclusive societies and create more opportunities for independent entrepreneurs in India and elsewhere.